Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils

European Journal of Clinical Pharmacology

Volumn 59, Issue 7, 2003, Pages 507-516

  Li, Shuren ^a   Dudczak, Robert ^a,d   Koller, Elisabeth ^b   Baghestanian, Mehrdad ^a   Ghannadan, Minoo ^a   Minar, Erich ^a   Pirich, Christian ^a   Angelberger, Peter ^e   Virgolini, Irene ^c,d   Li, Mei ^a   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c City of Vienna Hospital Lainz   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

Atherosclerosis; Lipoproteins; Statins

Indexed keywords

ATORVASTATIN; CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVALONIC ACID; SIMVASTATIN; STATIN; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BASOPHIL; CELL LINE; CHOLESTEROL SYNTHESIS; DRUG EFFECT; GENE ACTIVATION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID METABOLISM; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STEM CELL;

BASOPHILS; BINDING SITES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAST CELLS; RADIOLIGAND ASSAY; RECEPTORS, LDL; THYMIDINE; UP-REGULATION;

EID: 10744223811     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0668-1     Document Type: Article

References (37)

1. Brown MS, Goldstein JL (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340
2. Russell DW, Yamamoto T, Schneider WJ, Slaughter CJ, Brown MS, Goldstein JL (1983). cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. Proc Natl Acad Sci U S A 80:7501-7505
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al (1995) For the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hyper cholesterolemia. N Engl J Med 333:1301-1307
4. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 334:1383-1389
5. Endo A (1992) The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 33:1569-1582
6. Koh KK (2000) Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 47:648-657
7. Chen H, Ikeda U, Shimpo M, Shimada K (2000) Direct effects of statins on cells primarily involved in atherosclerosis. Hypertens Res 23:187-192
8. Lennernas H, Fager G (1997) Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 32:403-425
9. Kirshbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD (1992) Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 148:772-777
10. Kovanen PT (1993) The mast cell - a potential link between inflammation and cellular cholesterol deposition in atherogenesis. Eur Heart J [Suppl K]:105-117
11. Knol EF, Mul FP, Lie WJ, Verhoeven AJ, Roos D (1996) The role of basophils in allergic dieseas. Eur Respir J 22[Suppl]:S126-S131
12. Dvorak AM (1997) New aspects of mast cell biology. Int Arch Allergy Immunol 114:1-9
13. Metzler B, Xu Q (1997) The role of mast cells in atherosclerosis. Int Arch Allergy Immunol 114:10-14
14. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, et al (2001) The human mast cell: functions in physiology and disease. Front Biosci 6:D1109-D1127
15. Gardiner C, Harrison P, Chavda N, MacKie IJ, Machin SJ (1999) Platelet activation responses in vitro to human mast cell activation. Br J Haematol 106:208-215
16. Lee M, Sommerhoff CP, von Eckardstein A, Zettl F, Fritz H, Kovanen PT (2002) Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler Thromb Vasc Biol 22:2086-2091
17. Lee M, Metso J, Jauhiainen M, Kovanen PT (2003) Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells. J Biol Chem 278:13539-13545
18. Kokkonen JO, Kovanen PT (1989). Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages. J Biol Chem 264:10749-10755
19. Virgolini I, Li SR, Yang Q, Koller E, Sperr WR, Leimer M, et al (1995) Characterization of LDL and VLDL binding sites on human basophils and mast cells. Arterioscler Thromb Vasc Biol 15:17-26
20. 1 onto monocytes in patients with peripheral vascular disease. Arterioscler Thromb Vasc Biol 17:2066-2073
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
22. Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-260
23. Bilheimer DW, Eisenberg S, Levy RI (1972) The metabolism of very low density lipoproteins I. Preliminary in vitro and in vivo observation. Biochim Biophys Acta 260:212-221
24. Kishi K (1985) A new leukemic cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 9:381-387
25. Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345-355
26. Hayashi K, Nimpf J, Schneider WJ (1989) Chicken oocytes and fibroblasts express different apolipoprotein-B-specific receptors. J Biol Chem 264:3131-3139
27. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672
28. Brown MS, Goldstein JL (1998) The LDL receptor concept: clinical and therapeutic implications. In: Grundy S (ed) Bile acids and atherosclerosis, vol.15. Raven Press, New York, pp 85-93
29. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, et al (1999) Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 292:1-9
30. Motti C, Gnasso A, Cortese C (2000) Statins: similarities and differences in the pharmacological, clinical and laboratory aspects. Ann Ital Med Int 15:96-102
31. Scharnagl H, Schliack M, Loeser R, Nauck M, Gierens H, Jeck N, et al (2000) The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway. Atherosclerosis 153:69-80
32. Reihner E, Rudling M, Stahlberg D, Berglund L, Ewerth S, Bjorkhem I, et al (1990) Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 323:224-228
33. Brown MS, Faust JR, Goldstein JL (1978) Induction of 3-hydroxy-3- methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 253:1121-1128
34. Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, Allister E (2003) Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J Nutr 133:700-706
35. Vincent L, Soria C, Mirshahi F, Opolon P, Mishal Z, Vannier JP, et al (2002) Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models. Arterioscler Thromb Vasc Biol 22:623-629
36. Lindstedt KA, Kokkonen JO, Kovanen PT (1993) Inhibition of copper-mediated oxidation of LDL by rat serosal mast cells. A novel cellular protective mechanism involving proteolysis of substrate and oxidate stress. Arteriscler Thromb 13:23-32
37. Lindstedt KA, Kokkonen JO, Kovanen PT (1992) Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis. J Lipid Res 33:65-75